At least three people have died and 65 others have suffered vision issues stemming from contaminated eye drops.

The Centers for Disease Control and Prevention, in partnership with the Food and Drug Administration, said the issues were linked to drops for artificial tears. The people impacted by the contamination reported that they used at least 10 different brands of eye drops with EzriCare Artificial Tears being the most common.

Apotex and Pharmedica were among the brands added to the recall list.

Some notable symptoms of an eye infection include yellow, green or clear discharge from the eyes, pain or discomfort, blurry vision, red eye and increased sensitivity to light.

Last month, the FDA said Global Pharma healthcare, the India-based company that manufactures EzriCare products, did not adequately test for microbial bacteria and also failed to use proper tamper-proof packaging, which ultimately led to the unchecked outbreak.

Share:
More In Science
Advancements in Breast Cancer Care and Treatments
October is Breast Cancer Awareness Month. Over 240,000 cases of breast cancer are diagnosed each year but today's treatments give patients a better chance at beating the disease and living a healthy life. Cheddar News spoke with Dr. Mehran Habibi, director of breast surgery with Staten Island University Hospital; Dr. Holly Marshall, division chief of breast imaging at University Hospitals Cleveland; and Dr. Neil Iyengar, breast medical oncologist with Memorial Sloan Kettering Cancer Center about the progress made in treatments.
Load More